IN192527B - - Google Patents

Info

Publication number
IN192527B
IN192527B IN983DE2001A IN192527B IN 192527 B IN192527 B IN 192527B IN 983DE2001 A IN983DE2001 A IN 983DE2001A IN 192527 B IN192527 B IN 192527B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Purna Chandra Ray
Jayachandra Suresh Babu
Mohammad Slaman
Naresh Kumar
Original Assignee
Ranbaxy Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab filed Critical Ranbaxy Lab
Priority to IN983DE2001 priority Critical patent/IN192527B/en
Priority to PT02775017T priority patent/PT1432682E/pt
Priority to CA002461087A priority patent/CA2461087A1/en
Priority to DE60204334T priority patent/DE60204334T2/de
Priority to AT02775017T priority patent/ATE296287T1/de
Priority to JP2003530663A priority patent/JP2005521634A/ja
Priority to EP02775017A priority patent/EP1432682B1/en
Priority to CNA028204492A priority patent/CN1571769A/zh
Priority to US10/490,275 priority patent/US7148355B2/en
Priority to PCT/IB2002/003943 priority patent/WO2003027072A1/en
Priority to BR0212772-5A priority patent/BR0212772A/pt
Priority to ES02775017T priority patent/ES2242068T3/es
Priority to ARP020103594A priority patent/AR036623A1/es
Publication of IN192527B publication Critical patent/IN192527B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN983DE2001 2001-09-25 2001-09-25 IN192527B (ar)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IN983DE2001 IN192527B (ar) 2001-09-25 2001-09-25
PT02775017T PT1432682E (pt) 2001-09-25 2002-09-24 Processo para a preparacao de repaglinida
CA002461087A CA2461087A1 (en) 2001-09-25 2002-09-24 Process for the preparation of repaglinide
DE60204334T DE60204334T2 (de) 2001-09-25 2002-09-24 Verfahren zur Herstellung von Repaglinid
AT02775017T ATE296287T1 (de) 2001-09-25 2002-09-24 Verfahren zur herstellung von repaglinide
JP2003530663A JP2005521634A (ja) 2001-09-25 2002-09-24 レパグリニドの製法
EP02775017A EP1432682B1 (en) 2001-09-25 2002-09-24 Process for the preparation of repaglinide
CNA028204492A CN1571769A (zh) 2001-09-25 2002-09-24 瑞格列奈的制备方法
US10/490,275 US7148355B2 (en) 2001-09-25 2002-09-24 Process for the preparation of repaglinide
PCT/IB2002/003943 WO2003027072A1 (en) 2001-09-25 2002-09-24 Process for the preparation of repaglinide
BR0212772-5A BR0212772A (pt) 2001-09-25 2002-09-24 Processo para a preparação de repaglinida
ES02775017T ES2242068T3 (es) 2001-09-25 2002-09-24 Proceso de preparacion de repaglinida.
ARP020103594A AR036623A1 (es) 2001-09-25 2002-09-25 Proceso para la preparacion de repaglinida

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN983DE2001 IN192527B (ar) 2001-09-25 2001-09-25

Publications (1)

Publication Number Publication Date
IN192527B true IN192527B (ar) 2004-04-24

Family

ID=11097115

Family Applications (1)

Application Number Title Priority Date Filing Date
IN983DE2001 IN192527B (ar) 2001-09-25 2001-09-25

Country Status (13)

Country Link
US (1) US7148355B2 (ar)
EP (1) EP1432682B1 (ar)
JP (1) JP2005521634A (ar)
CN (1) CN1571769A (ar)
AR (1) AR036623A1 (ar)
AT (1) ATE296287T1 (ar)
BR (1) BR0212772A (ar)
CA (1) CA2461087A1 (ar)
DE (1) DE60204334T2 (ar)
ES (1) ES2242068T3 (ar)
IN (1) IN192527B (ar)
PT (1) PT1432682E (ar)
WO (1) WO2003027072A1 (ar)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018442A1 (en) * 2002-08-23 2004-03-04 Dr. Reddy's Laboratories Limited Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof
US7915421B2 (en) * 2003-05-14 2011-03-29 Cilag Ltd. Method for preparing phenyl acetic acid derivatives
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
CN100445275C (zh) * 2006-06-21 2008-12-24 浙江大学 一种合成瑞格列奈的工艺
US8101769B2 (en) 2007-02-15 2012-01-24 Actavis Group Ptc Ehf Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide
CN101772491A (zh) * 2007-06-06 2010-07-07 阿克塔维什集团Ptc公司 基本不含有二聚体杂质的瑞格列奈
CN101481363B (zh) * 2008-01-10 2011-05-04 江苏豪森药业股份有限公司 一种制备瑞格列奈的方法
CN101220007B (zh) * 2008-01-16 2010-09-15 浙江耐司康药业有限公司 一种制备瑞格列奈的方法
CN102267959B (zh) * 2011-07-06 2013-05-01 海南锦瑞制药股份有限公司 一种瑞格列奈晶体、其制备方法及含有该晶体的固体口服制剂
CN103012319B (zh) * 2011-09-20 2015-06-10 浙江九洲药业股份有限公司 瑞格列奈中间体的合成工艺改进
CN102633750A (zh) * 2012-03-26 2012-08-15 浙江昂利康制药有限公司 一锅法合成治疗糖尿病的药物瑞格列奈
CN102731436A (zh) * 2012-04-09 2012-10-17 海南中化联合制药工业股份有限公司 一种瑞格列奈的制备及精制方法
CN104557778A (zh) * 2015-01-09 2015-04-29 蔡伦 一种瑞格列奈的制备方法及其应用
CN105198838A (zh) * 2015-10-21 2015-12-30 河南普瑞制药有限公司 一种瑞格列奈的制备方法
CN105906583B (zh) * 2015-12-23 2018-03-09 嘉实（湖南）医药科技有限公司 一种瑞格列奈中间体的制备工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5965094A (ja) * 1982-10-06 1984-04-13 Sumitomo Chem Co Ltd セフアロスポリン化合物の製造法
US5312924A (en) * 1983-12-30 1994-05-17 Dr. Karl Thomae Gmbh Phenylacetic acid benzylamides

Also Published As

Publication number Publication date
US20050107614A1 (en) 2005-05-19
BR0212772A (pt) 2004-10-13
EP1432682A1 (en) 2004-06-30
CN1571769A (zh) 2005-01-26
ATE296287T1 (de) 2005-06-15
AR036623A1 (es) 2004-09-22
PT1432682E (pt) 2005-09-30
DE60204334D1 (de) 2005-06-30
EP1432682B1 (en) 2005-05-25
JP2005521634A (ja) 2005-07-21
ES2242068T3 (es) 2005-11-01
WO2003027072A1 (en) 2003-04-03
US7148355B2 (en) 2006-12-12
CA2461087A1 (en) 2003-04-03
DE60204334T2 (de) 2006-03-23

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ar)
BE2022C547I2 (ar)
BE2017C057I2 (ar)
BE2017C051I2 (ar)
BE2017C032I2 (ar)
BE2016C051I2 (ar)
BE2015C077I2 (ar)
BE2015C046I2 (ar)
BE2014C052I2 (ar)
BE2014C036I2 (ar)
BE2014C026I2 (ar)
BE2017C050I2 (ar)
BE2014C004I2 (ar)
BE2014C006I2 (ar)
BE2011C034I2 (ar)
BE2007C047I2 (ar)
AU2002307149A8 (ar)
BRPI0209186B1 (ar)
BE2016C021I2 (ar)
BE2014C008I2 (ar)
CH1379220H1 (ar)
BRPI0204884B1 (ar)
BE2017C059I2 (ar)
BE2012C051I2 (ar)
IN192527B (ar)